Paul Cutarelli, MD
Ophthalmology · Englewood, CONPI 1306927173
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (50.0%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 46.7% of the total. Reporting peaked in 2023 at $1,608 and has fallen 84.7% since, to $246 in 2025.
Across 38 payments — averaging $70.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$1K
- Alcon$1K
- Lensar, Inc.$137
- Rxsight Inc$134
- Carl Zeiss Meditec USA, Inc.$36
- Johnson & Johnson Surgical Vision, Inc.$31
- plus $61 from 3 others
What the payments were for
- Food & beverage$1,28448%
- Education$1,34050%
- Gifts$361%
- Entertainment$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 1 | $1,250 |
| Alcon | 29 | $1,031 |
| Lensar, Inc. | 1 | $137 |
| Rxsight Inc | 2 | $134 |
| Carl Zeiss Meditec USA, Inc. | 1 | $36 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $31 |
| Kala Pharmaceuticals, Inc. | 1 | $24 |
| Optos, Inc. | 1 | $19 |
| Biotissue Holdings Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,679 in reported general payments places this provider in the 70th percentile of 262 ophthalmology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 111 | $3,730 |
| Ketorolac Tromethamine | 96 | $1,961 |
| Ofloxacin | 88 | $849 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Englewood
- Mark PackerBoulder$3.5M
- Jon DishlerGreenwood Village$1M
- Mark DaceyDenver$370K
- Cristos IfantidesDenver$343K
- Geeta Lalchandani LalwaniBoulder$319K
- Richard DavidsonAurora$316K
- Steven DeweyColorado Springs$246K
- Jack ZamoraDenver$172K
- Eva KimDenver$95K
- Michael JansenDenver$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.